Navigation Links
Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients
Date:8/21/2014

eated hemophilia A. Patients received treatment twice weekly (45 IU/kg) or on-demand, and were followed for six months. The primary objective of the study was the reduction in ABR during the treatment period compared to on-demand treatment. The study also evaluated the safety and immunogenicity of the compound when administered on either prophylaxis or on-demand treatment regimens.

Baxter expects to submit a Biologics License Application (BLA) for BAX 855 to the U.S. Food and Drug Administration (FDA) before the end of 2014 and will present additional data in the coming months. In addition to an ongoing continuation study for patients who have completed the pivotal trial, the company is initiating a Phase 3, prospective, open-label, multi-center study to evaluate the safety and efficacy of BAX 855 among 60 previously treated patients under the age of 12 with severe hemophilia A. Consistent with guidelines published by the European Medicines Agency (EMA) that require a study in children less than 12 years of age prior to filing, Baxter expects to file a Marketing Authorization Application with the EMA upon the completion of the pediatric study.

BAX 855 is based on ADVATE, a full-length FVIII molecule with more than 10 years of real-world experience. Through a collaboration with Nektar Therapeutics (NASDAQ: NKTR), BAX 855 leverages proprietary PEGylation technology designed to extend the duration of activity of proteins in the body. This proprietary technology has been used for over 10 years in a number of approved medicines that treat chronic or serious conditions.

About ADVATE
ADVATE is a recombinant antihemophilic factor indicated for use in children and adults with hemophilia A (congenital factor VIII deficiency or classic hemophilia) for:

  • Control and prevention of bleeding episodes.
  • Perioperativ
    '/>"/>

SOURCE Nektar Therapeutics; Baxter International Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
2. Baxter And Halozyme Announce Positive Opinion For HyQvia For Treatment Of Primary And Secondary Immunodeficiencies In The European Union
3. FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard
4. Early Morning Insight: Baxter, CareFusion, Unilife, and Mindray Medical
5. Israeli Medical Device Company FlowSense Acquired by Baxter
6. Legal Actions, Quarterly Dividends, Collaborations, and New Appointments - Research Report on Johnson & Johnson, Zoetis, Abbott, Teva Pharmaceuticals, and Baxter
7. United States Regenerative Medicine Market Analysis to 2016 Featuring Baxter, Medtronic, Stryker & Zimmer
8. Biologics License Applications, Event Participations, and Stock Movements - Research Report on Baxter, WellPoint, Questcor Pharmaceuticals, CareFusion, and Hologic
9. Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific
10. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
11. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 Educating ... of the Association for the Advancement of Wound ... With support from AAWC,s corporate partners, the ... Portal on the AAWC website at ... wound care pathway with links to various CME/CEU ...
(Date:5/28/2015)... 28, 2015 Research ... addition of Jain PharmaBiotech,s new report  "RNAi ... their offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... silencing involves the use of double stranded ... material is processed into short 21-23 nucleotide ...
(Date:5/28/2015)... The controversy surrounding the use of ... (procedures to remove uterine fibroids) continues, as a ... Johnson & Johnson,s Ethicon, Inc. unit, which was ... to the report published by The Wall Street ... is trying to determine what the company knew ...
Breaking Medicine Technology:The Association for the Advancement of Wound Care Educates the Public 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 2Global RNAi Market Report 2015-2024 - Technologies, Markets and Companies 3Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 2Power Morcellator Attorneys at Bernstein Liebhard LLP Comment on Report That FBI Is Investigating Ethicon Morcellators 3
... , PHILADELPHIA , Jan. 26 ... has licensed LiquentConnect® - a hosted software as ... review, amend and submit regulatory dossiers.  Omnicare Clinical Research is ... serving the biopharmaceutical and medical device industries. , LiquentConnect ...
... WORTH, Texas and PETERBOROUGH, Ontario , Jan. ... marketing Collagenase SANTYL® Ointment to healthcare professionals in Canada ... debriding chronic dermal ulcers (e.g., pressure ulcers, vascular ulcers, and ... only enzymatic debrider available in the Canadian market. , ...
Cached Medicine Technology:Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients 2Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients 3Healthpoint Launches Collagenase SANTYL(R) Ointment in Canada 2Healthpoint Launches Collagenase SANTYL(R) Ointment in Canada 3
(Date:5/29/2015)... 29, 2015 M3 USA MDLinx.com, source ... 14 medical specialties, now offers The Smartest Rheumatologist ... of rheumatology disorders ranging from Fibromyalgia and Osteoporosis, to ... director of MDLinx, and Caroline Tredway, editorial head of ... it will have on the physicians who participate. Says ...
(Date:5/29/2015)... 2015 Abington Hospital – Jefferson ... first hospitals in the nation to join the ... practices and work toward achieving the Baby-Friendly USA© ... focusing on maternity care practices leading to Baby-Friendly ... and Prevention, EMPower is aimed at increasing breastfeeding ...
(Date:5/29/2015)... Dot Hill can mark one more item off her bucket ... Woods retirement community is the oldest woman to have flown ... was great fun!”, she exclaimed. “I’ve always wanted to jump ... they thought this would be ok.” , “We put on nylon ... she described. “I don’t remember it being noisy, but the ...
(Date:5/29/2015)... North Carolina (PRWEB) May 29, 2015 ... confirmed that the newest Red Hot & Blue restaurant at ... business on Thursday, May 7, 2015. “The Red Hot & ... center for 18 years, but we have moved to a ... are now in the middle of all the activities on ...
(Date:5/29/2015)... 2015 Johnson & Johnson and ... Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement with a ... his use of the antipsychotic medication. According to ... the third bellwether trial to involve male breast ... in Pennsylvania’s Philadelphia Court of Common Pleas, where ...
Breaking Medicine News(10 mins):Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2Health News:Indoor Skydiving Brings Thrills to Seniors 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3
... Despite the popularity of colon cleansing, there,s no evidence ... or in day spas -- offers any health benefits, a ... side effects ranging from vomiting to kidney failure and death, ... also called colonic irrigation or colonic hydrotherapy -- often involves ...
... WASHINGTON, Aug. 1Researchers at the Massachusetts Institute of Technology ... high-speed, three-dimensional (3-D) imaging of microscopic pre-cancerous changes in ... the Optical Society,s (OSA) open access journal Biomedical ... called optical coherence tomography (OCT), which offers a way ...
... is a mysterious developmental disease because it often leaves ... example, it is well documented that autistic children often ... as "you" instead of "I." A new brain ... by scientists at Carnegie Mellon University provides an explanation ...
... -- A new study seems to confirm the widely held ... e-mails, social media and news. Researchers analyzed the habits ... found that they checked their devices throughout their waking hours. ... opening the screen lock and accessing a single application. ...
... Alexandria, VA - The 2011 Annual Meeting & OTO ... and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ... convene September 11-14, 2011 in San Francisco, CA. ... and several hundred instruction course hours for attendees, the ...
... dietary counseling for obesity are heavily rooted in the ... ability to choose healthy foods and portion sizes consistent ... According to preventive medicine and behavioral ... new counseling approach that views obesity as a result ...
Cached Medicine News:Health News:Colon Cleansing Has No Health Benefit, May Harm: Report 2Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 2Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 3Health News:New high-speed 3-D imaging system holds potential for improved cancer screening 4Health News:New CMU brain imaging research reveals why autistic individuals confuse pronouns 2Health News:New CMU brain imaging research reveals why autistic individuals confuse pronouns 3Health News:Smartphones Really Are Habit-Forming: Study 2Health News:World's largest meeting of ear, nose and throat doctors 2Health News:Obesity counseling should focus on neurobehavioral processes, not personal choice, researchers say 2Health News:Obesity counseling should focus on neurobehavioral processes, not personal choice, researchers say 3
MAXM is a reliable benchtop solution for processing mid-size volume workloads. Features include three-dimensional VCS technology, continuous autoloading and easy-to-use data management capabilities....
... The LH 755 simplifies ... by integrating expert automation and ... It delivers reliable, accurate results ... the best slide quality with ...
Creatinine Test Kit (enzymatic, liquid reagents), Wavelength: 550 nm. Linear range: up to 150 mg/dL....
Kinetic and endpoint methods for the quantitative determination of creatinine in serum....
Medicine Products: